My Personal CFO LLC’s Globus Medical GMED Stock Holding History

My Personal CFO LLC’s Portfolio GMED Stock Details GMED Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-4	Closed	-$297	–	371
2022 Q4	$297	Buy	+4	New	+$272	﹤0.01%	834

Other funds holding GMED

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

Nuance Investments Kansas City, Missouri $717M AUM 3.8% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

GKIM

GW&K Investment Management Boston, Massachusetts $11.3B AUM 31.98% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return

My Personal CFO LLC's GMED Position: Q1 2023 in Review

My Personal CFO LLC sold out of Globus Medical (GMED) in Q1 2023, closing a stake of 4 shares — an estimated $297 sold.

My Personal CFO LLC first reported a position in GMED in Q4 2022 and held it in 1 quarter. The position peaked at $297 in Q4 2022. 390 funds tracked by Wall St. Rank hold GMED as of Q1 2023.

My Personal CFO LLC reported no remaining Globus Medical position as of Q1 2023 after selling out during the quarter.
My Personal CFO LLC sold 4 Globus Medical shares in Q1 2023, an estimated $297.
My Personal CFO LLC first reported a position in Globus Medical in Q4 2022 and held it in 1 quarter.
My Personal CFO LLC's Globus Medical position peaked at $297 in Q4 2022.
390 funds tracked by Wall St. Rank held Globus Medical as of Q1 2023.

Based on My Personal CFO LLC's 13F filing for Q1 2023, filed 21 Apr 2023.